U.S. Lawmakers Should Not Condone Efforts By Thailand To Issue Compulsory Licenses For Antiretrovirals, Opinion Piece Says
Main Category: HIV / AIDSAlso Included In: Pharma Industry / Biotech Industry
Article Date: 19 Oct 2007 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
U.S. lawmakers should not praise Thailand and other countries for issuing compulsory licenses to manufacture generic versions of patented antiretroviral drugs, Sally Pipes -- president and CEO of the Pacific Research Institute, which partially is funded by the pharmaceutical industry -- writes in an opinion piece in The Hill.
In a "staggering display of cluelessness," Rep. Tom Allen (D-Maine) and Sen. Sherrod Brown (D-Ohio) have sponsored a resolution that praises the Thai government for its decision to issue compulsory licenses and urges Congress not to enforce intellectual property standards, according to Pipes, who also serves as a health care adviser to former New York City Mayor Rudy Giuliani, who is running for the Republican presidential nomination writes. Allen and Brown think that Thailand is "playing the role of Robin Hood ... by stealing property rights from the companies that develop" antiretrovirals, Pipes writes, adding that such a view is "criminally naive."
Although the "Thai population is suffering from an AIDS epidemic," the country's government is "more interested in using this crisis to steal patents and develop its own drug business than providing Thai patients with the effective cures," according to Pipes. Thailand's actions "threaten to upset the economic incentives that allow Western firms to produce novel cures," she writes, adding, "Without patent protections, the drug industry as we know it would collapse, and development of new drugs would be significantly curtailed."
By encouraging the U.S. to allow other nations to issue compulsory licenses, Brown and Allen would "slaughter the goose that lays the golden eggs of medical innovation," Pipes writes, adding, "If this trend grows," the world "can say goodbye to the next AIDS cure," and that is "not something" Congress should "commend" (Pipes, The Hill, 10/18).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/86001.php>
APA
http://www.medicalnewstoday.com/releases/86001.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



